Leukemia
Showing NaN - NaN of 80
Leukemia, Lymphoma Trial in United States (SCRI-CAR22v2)
Recruiting
- Leukemia
- Lymphoma
- SCRI-CAR22v2
-
Los Angeles, California
- +4 more
Jan 18, 2023
Collecting and Storing Tissue From Young Patients With Cancer
Recruiting
- Acute Lymphoblastic Leukemia
- +13 more
- Cytology Specimen Collection Procedure
- Laboratory Biomarker Analysis
-
Birmingham, Alabama
- +68 more
Aug 4, 2022
Blood and Bone Marrow Samples in Chronic Myelogenous Leukemia
Active, not recruiting
- Leukemia
- DNA analysis
- +3 more
-
San Diego, California
- +160 more
Aug 2, 2022
Blood and Bone Marrow Samples From Previously Untreated Chronic
Completed
- Leukemia
- fluorescence in situ hybridization
- +6 more
-
San Diego, California
- +34 more
Aug 2, 2022
Bone Marrow and Blood Samples in Untreated Acute Myeloid
Completed
- Leukemia
- laboratory biomarker analysis
-
San Diego, California
- +45 more
Aug 2, 2022
Tissue and Blood Samples From Acute Myeloid Leukemia
Active, not recruiting
- Leukemia
- DNA analysis
- +7 more
-
Mountain View, California
- +76 more
Aug 2, 2022
Hematopoietic and Lymphoid System Tumor, Leukemia, Lymphoma Trial in Canada, United States (procedure, biological, other)
Active, not recruiting
- Hematopoietic and Lymphoid System Neoplasm
- +3 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +3 more
-
Birmingham, Alabama
- +42 more
Jul 20, 2022
Leukemia, Lymphoma Trial in Canada, United States (Patient-derived CD19- and CD22 specific CAR)
Recruiting
- Leukemia
- Lymphoma
- Patient-derived CD19- and CD22 specific CAR
-
Los Angeles, California
- +4 more
Apr 2, 2022
Leukemia Trial in Washington (Bortezomib, Pravastatin)
Terminated
- Leukemia
-
Washington, District of ColumbiaChildren's National Medical Center
Apr 2, 2021
Leukemia Trial in Canada, United States (rituximab, fludarabine phosphate)
Terminated
- Leukemia
- rituximab
- fludarabine phosphate
-
Anniston, Alabama
- +386 more
Apr 9, 2020
Leukemia Trial in Canada, United States (biological, drug, other, procedure)
Completed
- Leukemia
- anti-thymocyte globulin
- +10 more
-
Birmingham, Alabama
- +51 more
Apr 7, 2020
Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in United States (biological, drug, procedure, radiation)
Withdrawn
- Leukemia
- +4 more
- alemtuzumab
- +6 more
-
La Jolla, California
- +23 more
Nov 25, 2019
Lymphoma, Infection, Leukemia Trial in United States (Fluconazole, Voriconazole)
Completed
- Lymphoma
- +2 more
-
Birmingham, Alabama
- +32 more
Aug 1, 2016
Leukemia, Lymphoma Trial in United States (filgrastim, rituximab, cyclophosphamide)
Completed
- Leukemia
- Lymphoma
- filgrastim
- +12 more
-
San Diego, California
- +30 more
Jul 1, 2016
Leukemia Trial in United States (rituximab, fludarabine phosphate)
Completed
- Leukemia
- rituximab
- fludarabine phosphate
-
La Jolla, California
- +33 more
Jul 19, 2016
Leukemia, MDS Trial in United States (topotecan HCl)
Completed
- Leukemia
- Myelodysplastic Syndromes
- topotecan hydrochloride
-
Birmingham, Alabama
- +47 more
Jul 19, 2016
Anemia, Breast Cancer, Chronic Myeloproliferative Disorders Trial in Canada, United States (epoetin alfa, )
Completed
- Anemia
- +10 more
- epoetin alfa
- placebo
-
Scottsdale, Arizona
- +20 more
Jul 12, 2016
Leukemia Trial in United States (alemtuzumab, fludarabine phosphate)
Completed
- Leukemia
- alemtuzumab
- fludarabine phosphate
-
Birmingham, Alabama
- +49 more
Jul 1, 2016
Leukemia Trial in United States (G-CSF, asparaginase, cyclophosphamide)
Completed
- Leukemia
- G-CSF
- +10 more
-
Birmingham, Alabama
- +49 more
Jul 1, 2016